Laboratory testing found antibody drug from Eli Lilly is inactive against South African Variant
Shares of Beyond Meat spiked 18% after announcing a joint venture with PepsiCo to develop snack and beverage products made from plant-based protein
Shares of Moderna spiked 12.2% after the biotech company said that laboratory studies suggested that its COVID-19 vaccine should be effective against the emerging variants
New Jersey-based Merck has just abandoned its two experimental COVID-19 vaccine projects after early data showed they generated weak immune response.
The US CDC is stepping up efforts to track coronavirus mutations and keep vaccines and treatments effective against new variants until collective immunity is reached
Some EU Members Turn To Russia, China As AstraZeneca Vaccine Logistics Fail
With the Pfizer-BioNTech and Moderna Covid-19 vaccines authorized in the United States and being distributed and dosed, some of the attention is shifting to Johnson &...
Gilead Sciences says its antiviral Veklury should be effective against the new, more contagious COVID-19 variants discovered in The post Gilead says Veklury should work against...
United Airlines finished a turbulent FY20 flipping to a loss of $7.1 billion from a profit of $3 billion a year ago as the pandemic brought...
Morgan Stanley earned 22% more in 2020 over the previous year, resulting in the best year in its history.
Are predictions that the beginning of the end of the COVID-19 pandemic would mysteriously coincide with the Biden inauguration ringing true?
This article was originally published by Investors Alley. Investors Alley 6 Questions To Ask During This Earnings Season Every earnings season, I check the results from...
Over the past 12 months, Moderna’s (MRNA) share price has increased by a spectacular 517% driven by the prospect of Moderna’s COVID-19 vaccine
Human trials of a coronavirus vaccine combining Russia’s Sputnik V shot with Britain’s AstraZeneca/Oxford shot are expected to start in early February
Small-cap stocks have taken a back seat to large caps in recent years, but the relative drought is over. Or at least it’s faded in recent...
Social media giants Facebook and Twitter sparked debates after they banned Donald Trump on their platforms following the US Capitol attack.
SkyWest Airlines will receive $233 million in PPP Loans to help it pay for the wages and other benefits of thousands of SkyWest Airlines employees.
Risk management is a vital element of success for any trader in any market. No matter the size..
Johnson & Johnson published interim Phase I/IIa data in the New England Journal of Medicine showing the company's single-dose Covid-19 vaccine candidate created an immune response
Bitcoin (BTC) surged higher on Jan. 14, reaching $40,000 amid fresh evidence of new large buys on exchanges.
Regeneron Pharmaceuticals has signed an agreement with the U.S. for the additional supply of 1.25 million doses of its antibody cocktail for the use in non-hospitalized...
Target Corp. benefited from booming online sales growth during the holiday period as consumers piled up on their shopping from home due to pandemic-led restrictions. Target...
Carnival Corp. said it expects a larger than expected loss for the fourth quarter ending Nov. 30.
Immunity from Moderna Inc.’s Covid-19 vaccine should last at least a year, the company said at the J.P. Morgan Healthcare conference.
Shares of Velodyne Lidar sank 7.3% on Friday after the producer of lidar sensors reported lower-than-expected preliminary results for the fourth quarter and full-year 2020.
The UK has approved the Moderna coronavirus vaccine, hard on the heels of its go-ahead by the EU
Moderna’s CEO Claims Covid-19 mRNA vaccine is likely to offer protection of up to a couple of years
Shares of Germany’s CureVac spiked 20% in US pre-market trading after the biopharma company announced that it has teamed up with Bayer to complete development of...
After delaying its decision earlier this week, the EMA announced it has formally recommended authorizing Moderna’s Covid-19 vaccine
Scientists at the NIH and Moderna may take about two months to determine whether doses of the company’s Covid-19 vaccine can be halved